TITLE:
Metabolic Syndrome in People Living with HIV in Lome (Togo): Epidemiological Aspects and Associated Factors
AUTHORS:
Abdou Razak Moukaila, Edem Komi Mossi, Mouhaman-Inouwa Kpelafia, Komi Dzidzonu Nemi, Kossi Kodjo, Agbeko Kodjo Djagadou, Lidaw Déassoua Bawe, Akessiwe Akouda Patassi, Yawovi Mawufemo Tsevi, Ihou Majesté Wateba, Awalou Mohaman Djibril
KEYWORDS:
HIV, HAART, Metabolic Syndrome, Dyslipidemia, Hypertension, Hyperglycemia, Togo
JOURNAL NAME:
Open Journal of Endocrine and Metabolic Diseases,
Vol.10 No.4,
April
17,
2020
ABSTRACT: Introduction: People living with HIV (PLWHIV) are exposed to Metabolic Syndrome (MS), which increases their risk of having cardiovascular events and type 2 diabetes. No data on this subject is available in Togo. Objective: The objective of our study was to make an inventory of the metabolic syndrome among PLWHIV in Togo. Method: This was a prospective cross-sectional descriptive and analytical study on PLWHIV received at the day hospital of the Infectious Diseases Department of the Sylvanus Olympio University Hospital for a period of six months. Results: A total of 279 PLWHIV patients were enrolled, of which 237 (84.9%) were on Highly Active Antiretroviral Treatment (HAART) and 42 (15.1%) were naive. Metabolic syndrome has been demonstrated in 28.7% of the study population. Abdominal obesity was the most represented component of MS with a proportion of 57.7%. Risk factors associated with MS were female sex (OR = 3.01; CI: 1.52 - 5.93; p 2 (OR = 3.29; CI: 1.92 - 5.64; p 3 (OR = 1.85; CI: 1.06 - 3.20; p Conclusion: There is a need to screen MS for PLWHIV so that risk factors associated with it can be addressed early.